This Month’s Focus: Product Development/ Contract Testing
Defining the dosage strength for labeling of DPIs: Use, limitations and relevance of in vitro data
This article provides an overview of uniformity of delivered dose testing and labeling, and considers requirements from the USP, Ph. Eur., EMA and FDA.
Point of View: Recommendations to a young scientist to pursue inhalation research
In this “letter to students,” the author sees exciting opportunities ahead for young scientists willing to take on the challenges in inhalation therapy research and development.
Back Page: US FDA approves OTC, non-CFC-based Primatene® Mist; Patient advocacy groups object
The approval makes Primatene Mist the only asthma inhaler available in the US without a prescription. However, patient advocacy groups have expressed serious concerns.
Cross-Industry Organizations: IPAC-RS: An update on recent activities
The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) and its working groups continued to advance a number of activities throughout 2018.
A preview of Respiratory Drug Delivery (RDD®) Europe 2019
Respiratory Drug Delivery (RDD®) Europe 2019 will be held May 7-10, 2019 in Lisbon, Portugal, at the Estoril Congress Center.
Previewing the Inhalation & Respiratory Drug Delivery USA Congress
The 2nd Annual Inhalation & Respiratory Drug Delivery USA Congress will be held in San Diego, CA, US, March 18-19, 2019.
Applications of automated SEM-EDS for inhalable drug products
The regulatory landscape for OINDPs—the biggest shake-up in a generation?
Back Page: An improved test for asthma in children
Cross-industry organizations: INTFG
2019 ISAM Congress
January: Reference and Buyer’s Resource
February: Product Development/ Contract Testing
June: Nasal Delivery/Nebulizers
August: Particle Characterization
1155 Northland Drive
St. Paul, MN 55120
Inhalation Article Guidelines
Technical article requirements
The article should be technical and educational, but not promotional. It must be new, not previously published and must be at least 50% different from your previous articles or other articles you are simultaneously developing on the same subject.
All discussions of products or technologies must be in an unbiased, non-promotional, educational manner. If your article discusses products that have been commercialized or are in development, please be aware of the following: Inhalation takes a very limited approach in discussing products, usually listing only product name, delivered drug name and company name, unless a description is provided by the particular company that owns a product, such as in a case study article or product news release. In that way, each company can choose the information it wishes to discuss or disclose about its own products, rather than being discussed by an outside party with no ability to comment prior to publication. However, if an article is a case study, presentation of a novel technology or news article written by the owner company or its representative such as a scientist or consultant, we are happy to consider all information or data they wish to disclose, provided it is presented in a fair-balanced manner.
The article should be 2,500-3,500 words and must include at least five references or items for recommended reading.
We encourage images and/or data tables and have space for three or four of them. We’re flexible about that number so let us know if you need more image space. We also like to publish an additional photo or illustration at the beginning of the article. Images should be sent as separate files that meet the following specifications: high resolution, 300 dpi at a size of 7 x 7 inches and in only JPG, TIF or EPS formats.
Please be aware, due to copyrights, if you use figures or tables from articles that have been previously published in other journals, you must obtain permission from those journals in order to use the images. If you are an author on the published article in question, you may still need permission but there should be no fees from the other journal. If you are not an author and the other journal wants to charge you fees for usage, please contact us before proceeding. We do not want authors incurring costs in order to publish in Inhalation and there may be alternate approaches to citing information that could be used. Also, “open journals” do not charge for image use. If you have any questions or concerns, please contact us.
Editorial board review and production
All of our articles are peer-reviewed and must be accepted by our editorial board or a designated reviewer in order to be published. When you send us the article, it will go to a member of the board and we will coordinate communication between you. Once an article is accepted, we handle production and you will see the final article in layout before it goes to print or is published in the digital edition.